News

Yoani Matsakis President of Telemedicine Technologies will be delivering an engaging speech at the upcoming “𝐇𝐀𝐂𝐑𝐎 [𝐇𝐞𝐥𝐥𝐞𝐧𝐢𝐜 𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐂𝐑𝐎𝐬] 𝐂𝐋𝐈𝐍𝐈𝐂𝐀𝐋 𝐓𝐑𝐈𝐀𝐋𝐒 𝐅𝐎𝐑𝐔𝐌 – 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬” 𝐨𝐧 𝐉𝐮𝐧𝐞 𝟖𝐭𝐡 at the prestigious Divani Caravel Hotel in Athens, Greece. Mr. Matsakis’s speech, titled “𝙏𝙝𝙚 𝙀𝙐𝘾𝙍𝙊𝙁 𝙂𝘿𝙋𝙍 𝘾𝙤𝙙𝙚 𝙤𝙛 𝘾𝙤𝙣𝙙𝙪𝙘𝙩 𝙛𝙤𝙧 𝘾𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝, 𝙬𝙝𝙚𝙧𝙚 𝙖𝙧𝙚 𝙬𝙚, 𝙖𝙣𝙙 𝙬𝙝𝙖𝙩 𝙘𝙖𝙣 […]

Wednesday may 24 TELEMEDICINE TECHNOLOGIES will be present at SantExpo on the OVHcloud stand as a partner of the “Open Trusted Cloud” program. Our president Yoani Matsakis will be representing Telemedicine Technologies, and wil intervene next to Mathieu Godart, CTO and co-founder of SÊMEIA and Emmanuel MEYRIEUX, Client Security manager at OVHcloud. Throughout the day you […]

Fierce Biotech The FDA seems to be satisfied that Pfizer’s RSV vaccine is safe and effective for administration in pregnant women to protect infants from severe disease. The agency’s confidence was revealed in briefing documents filed ahead of an advisory committee meeting set for Thursday. The Vaccines and Related Biological Products Advisory Committee will consider […]

Trial Site News The World Health Organisation (WHO) decided Thursday May 4, 2023, to end the COVID-19 public health emergency of international concern (PHEIC). TrialSite cautions that this is a provisional (temporary) status while WHO considers its forward-looking options (2023-2025). Importantly, in “The COVID-19 Emergency is Over, Sort of,” TrialSite reports that in America some […]